Ryuhjin Ahn

Ryuhjin Ahn

Massachusetts Institute of Technology

H-index: 13

North America-United States

About Ryuhjin Ahn

Ryuhjin Ahn, With an exceptional h-index of 13 and a recent h-index of 12 (since 2020), a distinguished researcher at Massachusetts Institute of Technology, specializes in the field of tumor immunology, signal transduction, phosphoproteomics, immunopeptidomics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Characterizing signaling in macrophage-GBM cell coculture

Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model

DIPG-39. SIGNALING NETWORKS IN PEDIATRIC-TYPE DIFFUSE HIGH GRADE GLIOMAS

Assessment of The Impact of Oncolytic Virotherapy on The Immunopeptidome Profile of Tumor by Utilizing GEMM Derived Immunocompetent GBM Models

Antigen discovery for the development of cancer immunotherapy

Investigative needle core biopsies for multi-omics in Glioblastoma

Deciphering the immunopeptidome in vivo reveals new tumour antigens

STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer

Ryuhjin Ahn Information

University

Position

___

Citations(all)

525

Citations(since 2020)

463

Cited By

195

hIndex(all)

13

hIndex(since 2020)

12

i10Index(all)

14

i10Index(since 2020)

14

Email

University Profile Page

Google Scholar

Ryuhjin Ahn Skills & Research Interests

tumor immunology

signal transduction

phosphoproteomics

immunopeptidomics

Top articles of Ryuhjin Ahn

Characterizing signaling in macrophage-GBM cell coculture

Cancer Research

2024/3/22

Ryuhjin Ahn
Ryuhjin Ahn

H-Index: 6

Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model

Frontiers in immunology

2023/12/28

DIPG-39. SIGNALING NETWORKS IN PEDIATRIC-TYPE DIFFUSE HIGH GRADE GLIOMAS

Neuro-Oncology

2023/6

Ryuhjin Ahn
Ryuhjin Ahn

H-Index: 6

Assessment of The Impact of Oncolytic Virotherapy on The Immunopeptidome Profile of Tumor by Utilizing GEMM Derived Immunocompetent GBM Models

The Journal of Immunology

2023/5/1

Antigen discovery for the development of cancer immunotherapy

2023/3/1

Ryuhjin Ahn
Ryuhjin Ahn

H-Index: 6

Investigative needle core biopsies for multi-omics in Glioblastoma

medRxiv

2023

Deciphering the immunopeptidome in vivo reveals new tumour antigens

Nature

2022/7/7

STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer

Nature Communications

2021/6/3

Clinical potential of kinase inhibitors in combination with immune checkpoint inhibitors for the treatment of solid tumors

2021/3/5

Ryuhjin Ahn
Ryuhjin Ahn

H-Index: 6

p66ShcA potentiates the cytotoxic response of triple-negative breast cancers to PARP inhibitors

JCI insight

2021/2/2

p66ShcA functions as a contextual promoter of breast cancer metastasis

Breast Cancer Research

2020/12

Ryuhjin Ahn
Ryuhjin Ahn

H-Index: 6

The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation

Journal of Biological Chemistry

2020/7/31

Ryuhjin Ahn
Ryuhjin Ahn

H-Index: 6

Nicolas Bisson
Nicolas Bisson

H-Index: 10

CD44 promotes PD-L1 expression and its tumor-intrinsic function in breast and lung cancers

Cancer research

2020/2/1

See List of Professors in Ryuhjin Ahn University(Massachusetts Institute of Technology)